BR112016018372A2 - moléculas de anticorpo para vírus da dengue e suas utilizações - Google Patents

moléculas de anticorpo para vírus da dengue e suas utilizações

Info

Publication number
BR112016018372A2
BR112016018372A2 BR112016018372A BR112016018372A BR112016018372A2 BR 112016018372 A2 BR112016018372 A2 BR 112016018372A2 BR 112016018372 A BR112016018372 A BR 112016018372A BR 112016018372 A BR112016018372 A BR 112016018372A BR 112016018372 A2 BR112016018372 A2 BR 112016018372A2
Authority
BR
Brazil
Prior art keywords
antibody molecules
dengue virus
virus antibody
dengue
molecules
Prior art date
Application number
BR112016018372A
Other languages
English (en)
Inventor
Babcock Gregory
Myette James
Viswanathan Karthik
Robinson Luke
Shriver Zachary
Original Assignee
Visterra Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Visterra Inc filed Critical Visterra Inc
Priority claimed from PCT/US2015/011965 external-priority patent/WO2015122995A1/en
Publication of BR112016018372A2 publication Critical patent/BR112016018372A2/pt

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
BR112016018372A 2014-02-11 2015-01-20 moléculas de anticorpo para vírus da dengue e suas utilizações BR112016018372A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461938646P 2014-02-11 2014-02-11
US201461017970P 2014-06-27 2014-06-27
US201462046379P 2014-09-05 2014-09-05
PCT/US2015/011965 WO2015122995A1 (en) 2014-02-11 2015-01-20 Antibody moleules to dengue virus and uses thereof

Publications (1)

Publication Number Publication Date
BR112016018372A2 true BR112016018372A2 (pt) 2018-05-08

Family

ID=62090112

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016018372A BR112016018372A2 (pt) 2014-02-11 2015-01-20 moléculas de anticorpo para vírus da dengue e suas utilizações

Country Status (1)

Country Link
BR (1) BR112016018372A2 (pt)

Similar Documents

Publication Publication Date Title
FIC20230014I1 (fi) Foslevodopa ja foskarbidopa
HK1254337A1 (zh) April的抗體分子及其用途
CL2016002252A1 (es) Anticuerpos anti-egfrviii y usos de los mismos
DK3116909T3 (da) Antistofmolekyler til lag-3 og anvendelser deraf
DK3099172T3 (da) Modificeret biologisk bekæmpelsesmiddel og anvendelser deraf
SG11201606624WA (en) Antibody moleules to dengue virus and uses thereof
DK3149042T3 (da) PD-L1-antistoffer og anvendelser deraf
DK3229838T3 (da) Anti-C10orf54-antistoffer og anvendelser deraf
DK3265575T3 (da) Cd20-bindende molekyler og anvendelser deraf
BR112016016289A2 (pt) heteroaris e usos dos mesmos
CL2016002569A1 (es) Anticuerpos, composiciones farmacéuticas y usos de los mismos
MA40933A (fr) Difluorométhyl-aminopyridines et difluorométhyl-aminopyrimidines
HK1248721A1 (zh) 抗體分子及其用途
DK3242685T3 (da) Cxcr4-bindende molekyler
DK3236991T3 (da) Fgf21-derivater og anvendelser deraf
DK3417058T3 (da) Sortase-modificerede molekyler og anvendelser deraf
DK3110447T3 (da) Anti-EGFR-antistof og anvendelser heraf
BR112017018932A2 (pt) etv2 e usos do mesmo
BR112017010263A2 (pt) fluidos e método incluindo nanocelulose
CR20180079A (es) Moléculas de fusión
DK3606953T3 (da) Fgfr3-bindende molekyler
DK3371324T3 (da) Virusbiomarkører og anvendelser deraf
IL252932A0 (en) Anti-cxcl12 antibody molecules and their uses
BR112016018372A2 (pt) moléculas de anticorpo para vírus da dengue e suas utilizações
ES1114855Y (es) Conjunto de bandeja, de soporte de pantalla y de pantalla

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B350 Update of information on the portal [chapter 15.35 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B25G Requested change of headquarter approved

Owner name: VISTERRA, INC. (US)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]